Barclays’s AllianzIM U.S. Equity Buffer10 Dec ETF DECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4K Buy
+444
New +$17K ﹤0.01% 4611
2025
Q4
– Sell
-4,179
Closed -$148K – 5331
2025
Q3
$148K Sell
4,179
-1,142
-21% -$39.2K ﹤0.01% 4474
2025
Q2
$178K Sell
5,321
-1,061
-17% -$33.4K ﹤0.01% 4350
2025
Q1
$198K Buy
+6,382
New +$204K ﹤0.01% 4045

Other funds holding DECT

Barclays's DECT Position: Q2 2026 in Review

Barclays opened a new position in AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) in Q2 2026: 444 shares worth $17.4K. The stake represents ﹤0.01% of the portfolio and ranks #4611 among its holdings. This is a return to the name: Barclays previously reported a position in DECT as recently as Q3 2025.

Barclays first reported a position in DECT in Q1 2025 and has held it in 4 quarters since. The position peaked at $198K in Q1 2025. 48 funds tracked by Wall St. Rank hold DECT as of Q2 2026.

  • Barclays held 444 shares of AllianzIM U.S. Equity Buffer10 Dec ETF worth $17.4K as of Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Dec ETF was a new Barclays position in Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Dec ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4611 holding.
  • Barclays first reported a position in AllianzIM U.S. Equity Buffer10 Dec ETF in Q1 2025 and has held it in 4 quarters since.
  • Barclays's AllianzIM U.S. Equity Buffer10 Dec ETF position peaked at $198K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Dec ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.